Polymyositis is one form of inflammatory myopathy. In some patients, this disease does not entirely respond to conventional initial therapy with glucocorticoid, methotrexate and azathioprine. Multiple options exist for treating these patients, but only intravenous immune globulin has been subjected to a randomized clinical trial. We report here on a case of polymyositis that did not respond to multiple drug therapy, but it did respond to tacrolimus. After treatment with tacrolimus, the patient���s disease has been well controlled for many years
A 72-year-old man who had been diagnosed with polymyositis (PM) was admitted to our hospital for pne...
Tacrolimus, also known as FK506, is an immunosuppressive agent widely used for the prevention of acu...
The inflammatory myopathies, commonly described as idiopathic, are the largest group of acquired and...
Polymyositis is one form of inflammatory myopathy. In some patients, this disease does not entirely ...
The initial approach to the treatment of patients with inflammatory myopathy is critical in determin...
The treatment of the immune-mediated inflammatory myopathies remains largely empirical. Corticostero...
National audienceINTRODUCTION: Anti TNF-alpha agents may represent a possibility of treatment in cas...
BACKGROUND: Polymyositis (PM) is a chronic, disabling, and progressive inflammatory disease with mus...
We made a comparative clinical, immunopathological and therapeutic evaluation in 17 patients with po...
Item does not contain fulltextBACKGROUND: The inflammatory myopathies are a heterogeneous group of d...
The three major forms of immune-mediated inflammatory myopathy are dermatomyositis (DM), polymyositi...
The idiopathic inflammatory myopathies include polymyositis and dermato-myositis, which tend to be r...
Dermatomyositis and polymyositis may affect children and adults and are now widely recognized as ma...
Idiopathic inflammatory myopathies, such as polymyositis and dermatomyositis, share common clinical ...
Polymyalgia rheumatica (PMR) is an idiopathic inflammatory disease characterized by pain and stiffne...
A 72-year-old man who had been diagnosed with polymyositis (PM) was admitted to our hospital for pne...
Tacrolimus, also known as FK506, is an immunosuppressive agent widely used for the prevention of acu...
The inflammatory myopathies, commonly described as idiopathic, are the largest group of acquired and...
Polymyositis is one form of inflammatory myopathy. In some patients, this disease does not entirely ...
The initial approach to the treatment of patients with inflammatory myopathy is critical in determin...
The treatment of the immune-mediated inflammatory myopathies remains largely empirical. Corticostero...
National audienceINTRODUCTION: Anti TNF-alpha agents may represent a possibility of treatment in cas...
BACKGROUND: Polymyositis (PM) is a chronic, disabling, and progressive inflammatory disease with mus...
We made a comparative clinical, immunopathological and therapeutic evaluation in 17 patients with po...
Item does not contain fulltextBACKGROUND: The inflammatory myopathies are a heterogeneous group of d...
The three major forms of immune-mediated inflammatory myopathy are dermatomyositis (DM), polymyositi...
The idiopathic inflammatory myopathies include polymyositis and dermato-myositis, which tend to be r...
Dermatomyositis and polymyositis may affect children and adults and are now widely recognized as ma...
Idiopathic inflammatory myopathies, such as polymyositis and dermatomyositis, share common clinical ...
Polymyalgia rheumatica (PMR) is an idiopathic inflammatory disease characterized by pain and stiffne...
A 72-year-old man who had been diagnosed with polymyositis (PM) was admitted to our hospital for pne...
Tacrolimus, also known as FK506, is an immunosuppressive agent widely used for the prevention of acu...
The inflammatory myopathies, commonly described as idiopathic, are the largest group of acquired and...